Background: This paper offers mortality risk rankings for Iranian mortality data. It extends methods to include mixed cohorts, tests changes in mortality risks, compares measures of risk and discusses public policy implications. Methods: The methodology used in risk measures takes current practice and extends it to include variations in population dynamics. The specification is presented and compared with existing literature. Results: Our findings confirm literature results in the re-ordering that takes place when different risk measures are used. In addition, we find there is consistency in risk rankings between 1999 and 2000 records of Iranian mortality data. Thus, these risk measures are stable, robust across time and relay risk information consistently. Conclusions: There are considerable implications in adopting particular risk measures for public policy. However, given properties of risk measures discussed here, it is clear that policy makers can select relevant risk measures depending on their priorities.
Introduction
A major concern within health industries is some quantitative measure of mortality risk that may be faced by a member of population. Measures of mortality that only take the probability of death to represent risks faced by an individual do not take into account the timing of death and any discounting that may be present. Whereas, remaining life at risk, given life expectancies of individuals, are important in evaluating risks faced by the population as evidenced in the literature (1-7). Risk of death from different causes could be different due to the age of the individual exposed to such risks. Not all individuals, irrespective of their age, are subject to the same mortality risk from any cause. For example, death from a malignant neoplasm is far more likely to threaten the life of a 60 yr old than an infant is. While, congenital anomalies expose infants to higher risk that are almost nonexistent in older age groups. The method for incorporating other information that affects measurement of risk as suggested in (5) takes into account factors other than just the probability of death. It includes life expectancies at different ages to represent the remaining life at risk for an individual. As individuals may face risks from different ailments, then the incorporation of life expectancies brings in some measure of the magnitude of risk that is ex-ante based on a number of years the individual is expected to live. Life expectancies are given from life tables, which extrapolate remaining lives for individuals in all ages up to 100. In order to have some quantitative measure of lives lost, the expected years of life lost (EYLL) which is in a statistical sense an expected value of each life lost, provide a measure of human life lost because of each death following exposure to a risk. This factor is mainly the reason why a reordering of major causes of death ranks, takes place. The implication for health and safety regulation thus follows from this reordering of ranks of the major causes of death. As pointed out in (8) (9) in most health services industries, a greater portion of health expenditure falls on therapy, for a few who experience an ailment. Thus, substantial financial resources are devoted to a few who are identified with having a condition. Whereas the re-ordering of these major causes of death changes the way, health policy and regulation can be adopted. Thus, preventing or reducing the risk of these conditions for people who have not yet been diagnosed as having a particular condition. Of course, this is a major concern within the economics profession and the health industry to evaluate the costs and benefits of public resources and to suggest courses of action for policy making. Finally, as many health risks take effect in time and so there is a period during which the individual appears healthy while symptoms of a condition has not shown itself, a time lag between exposure and incidence of death is considered. We also provide a lag response rate estimated for all major conditions and the results confirm those found in (5) . However, we are aware that such lag responses are ad-hoc. Some conditions take effect without any time lag, as in most accidents. Thus, it is meaningless to consider a measure of risk that lags the effect of some condition with immediate death implications. This paper is presented in three sections. Section one presents the model adopted in here with extensions to include birth rates. Section two presents the empirical findings in four tables. Table 1 provides estimates for probability of death from major causes, life lost expectancies, expected years of life lost and the corresponding estimates that are discounted and then lagged. Table 2 ranks these major conditions based on probability of death, life lost expectancies and expected years of life lost and provides evidence for the reordering that takes place because of this method of measuring mortality risks. Tables 1 and 2 are estimates in eighteen groups of major conditions, thus aggregating the information that is provided in Tables 3 and 4 . The aggregation will allow a comparison to be made in section three. Table 3 is similar to Table 2 except that the estimates are further sub-grouped in 150 headings. In Section three we calculate nonparametric tests for the existence of any shift in population distributions and find correlations in our mortality risk rankings for 1999 and 2000 data. Section four provides a comparison between our findings and those of the literature and concludes the study with further research suggestions.
Model specification
We adopt the methodology in (5) and offer extensions. That is in calculating mortality risk measures, which in addition to the lifetime probability of death from any condition faced by an individual, takes into account the life expectancy of those individuals at every age (x). Individuals face different risks from a condition depending on their age. The magnitude of measures of lives lost is thus affected by both the probability of death from a condition at a particular age and the individual's life expectancy at that age. Therefore, the measures of mortality risk estimated in this way, changes the rank order of mortality risk in this model. To be specific, a hypothetical cohort of 0 N people born at time t= 0 are followed for T years. Survivors aged t, t S at the end of every time period are given by
Where t g is the probability of death in time period t and for 0 N people born at t=0, death at time t implies they died aged t. For a cohort this implies all individuals who die are t years old, i.e. t= x where x represents age. However,
where jt g the probability of death is aged t from condition j faced by the members of the cohort. Published statistics also provide information about the number of t-year olds who have died from condition j. 
Where t l represents life expectancy at age t and obtained from life tables. The information about life expectancies in our model is obtained from (11) . While the estimates for expected years of life lost EYLL is obtained from
Where j p is the lifetime probability of death from an ailment. The estimated discounted and lagged values of [2] and [3] are obtained using standard calculus and are given by ( ) ( ) ( )
Where i, is the rate of discount and set to 3%, as in (5) and the results are presented in Tables 1  and 3 . However, it is worth noting that this 3% rate of discounting is the best estimate available, although it is rather ad-hoc. The evidence to support this rate of time preference is based on the goodness of fit presented in a number of regressions that examine factors affecting mortality risk perceptions. But the rate of time preference as may be indicated by inter-temporal decisions of individuals needs a more extensive discussion (3, 7, 8, 10) . In discussions involving environmental issues, the role of discount rate is central to cost-benefit analysis, but finding the "right" discount rate has always been problematic (9) . In order to calculate lagged values of LLE and EYLL by t years, equations in [4] and [5] are multiplied by ( )
. This will evaluate the corresponding deferred symptom factor that may be present in some health risks. While the medical indication to verify the length of time lag for each condition is not provided by published data, we have insufficient information to justify any length of time lag. Thus this ten-year lag is, once again, rather ad-hoc. At best, the statistical methodology of best fitting regressors to explain variations in dependent variable, namely risk perception, is not always "medically" accurate in reflecting the correct lag response between exposure and the incidence of death. We also wish to make our theoretical model more accountable to the fact that population under study includes birth as well as death rates. We assume birth, death rates are uniform and equal throughout the year, and there is no immigration or emigration such that the population remains stable. Hypothetical cohorts that construct theoretical models with changing populations, allowing variation in birth and death rates, are found in the demographic literature as in (12). The analysis in this paper tries to include birth rates using component method used in demographic studies. 
Where t b is the birth rate and t g is the death rate in period t and
If however, we disallow the inflow of newborn in our population with 0 = t b in [6] and assume a cohort in period t, we then obtain equation [2] as a special case. Taking note of the fact that information about population statistics includes newborns, thus there is an inflow in the population as well as an outflow. Therefore, mortality measures are better represented in this way. The corresponding values of LLE in [2] , EYLL in [3] , the discounted and lagged values in [4] and [5] of our mortality measures follow from equation [6] . But, the probability of death from a condition j in year t is found by
In addition, the lifetime probability of death for a condition is given by
Where the probability of death for x year olds from condition j is
Where, jx D is the number of x year olds died from condition j and tx D is the number of x year olds died in period t. Here jx p is not equal to jt p unless we have a cohort. However, not all births or deaths take place or are supervised under ministry run health centers. The underreporting of deaths may be more than births as they may involve expenses for the bereaved and not reporting may entail continuation of certain state benefits. Failure to report a birth or death has also legal and financial implications where beneficiaries of any left state, require official certification. Overall these records are representative of the population and the best available.
Empirical findings
In our model, data were obtained from official statistics as published in the Iranian Ministry of Health Mortality Tables Annual Almanac (13) (14) (15) (16) (17) . These tables provide information about recorded deaths for 150 causes. Age at death is recorded and the statistics provide fourteen different age groups in which records are available. The classification also aggregates these 150 ailments into seventeen broader categories. This broad grouping enables us to make comparisons with other findings.
We present the first set of our findings in Table 1 where seven measures are estimated in eighteen categories. The probability of death is found directly from data and represents the ratio of the number of deaths from a condition to total number in the sample. As such, it represents an expost estimate of a measure of risk that individuals may consider for any health condition. Therefore, the probabilities offer some magnitude of a health risk based on the existing recorded information and are a measure of risk after the event.
The novelty of this model is in the comparison that is made between measures of risk that represent an ex-ante quantitative measure and those that are ex-post. LLE reflects a quantitative measure of lives lost, but subject to life expectancy of all individuals that are likely to be affected by a particular condition. It is therefore, conditional and weighted according to the number of years those individuals affected, might have expected to live. Thus, it offers an ex-ante quantitative measure of risk that is faced by a member of population. The EYLL is by definition the product of probability of death and LLE. It is therefore a weighted quantitative measure, which radically reorders mortality risk ranking. The rank orders are shown in Tables 2 and 3 . As it is seen in Table 2 Circulatory diseases are the most risky and ranks 1. Whereas according to the number of years of life lost, it ranks 17. This condition is in contrast with prenatal disorders that result in the highest years of life lost, since those affected are infants and expected to live much longer in the absence of the health risk. The rank orders according to LLE are highest for prenatal disorders and nearly the last for Circulatory diseases. As pointed out in (8, 14) a critical decision has to be made regarding public finances directed to health services and health insurance. The ranking here clearly indicates that any decision about funding and costing of medical care that is based on priorities, is dramatically affected by mortality risk measures adopted. Table 3 and 4 are starred. This is in order to avoid lagging the effect of any health risk that takes effect without any time delay such as in most accidents. In Table 3 there are also two categories that are not well defined 137 & 151: The "symptoms and other ill-defined conditions" plus "unspecified causes". As data stand, the amount of unexplained death probability is 0.04095 plus 0.0369 i.e. 0.07785 or 7.8% of all deaths. In order to see how demographic composition of this group may affect EYLL, a look at the age at death is helpful. For "symptoms and other ill-defined conditions" the largest count is 3221 out of a total 8679, which are in the 65+ age group. Perhaps due to old age, the significance of cause of death has been overlooked. While for the "unspecified causes", the largest count of 2968 out of a total 7820 is for aborted pregnancies. Again, perhaps due to a very early form of life, cause of death is overlooked. Raw data includes abortive deaths and stillbirths and it might be argued that these two categories should be excluded. However, taking an economic point of view, both of these categories impose a cost on people and health services and are therefore included in the calculations of EYLL. We have also calculated EYLL for this 7.8% "unspecified" deaths based on age at death that is available for each record. Therefore, for the 215 death records for the age group 5-9 yr that were due to "symptoms and other ill-defined conditions" or just "unspecified" the calculated EYLL takes age composition into account.
The results in Table 4 giving rank orders for an extensive list of medical conditions highlight how this model changes the priority that is attached to any ailment may be contrary to the perceived image. But it is quite clear how reordering is affecting priorities. The ranking based on the probability of death is quite markedly different from the LLE measure. The EYLL also offer a somewhat in between measure of mortality risk than the probability of death or LLE. It is also worth noting that aggregation also affect the ranking as it is seen in Tables 2 and 4 . In Table 2 , it is shown that heart conditions are the riskiest, while in Table 4 the old age appears the most risky condition. This condition, i.e. senility (old age) is put in the "ill defined" category in Table 2 , thus ranking second. In addition to providing disaggregated information for the medical profession, Table 4 may also provide indications as to the level of insurance coverage that may be needed. This can be seen by noting risks involved. The higher is the ranking, the higher insurance premium. However, discussions regarding the consequences of insurance premiums and cost-effectiveness of various decisions based on this reordering are beyond this study (15) . 
Tests
Here we present the results of nonparametric tests with the intention of examining if there has been any tendency for the data to shift between these two years. This is done using the MannWhitney U test, which detects shifts in the distribution of our mortality risk ranking. The results presented in section 2 enable us to examine ranks using nonparametric methods. We have ranks of various mortality risk measures and we wish to know if mortality risk ranking is significantly different between these two years. Differences between these two mortality data could be in the form of a shift among various causes of death between the two years. Ranks of some causes may have changed and therefore we would like to know if there are any significant changes in mortality risk ranking. Since we are dealing with ranks, nonparametric tests are used.
Procedures to carry out these tests are found in many statistical texts as in (16) (17) (18) (19) . The Mann-Whitney U test for a change in the location of population distribution is calculated and the results are shown in Table 5 . We have also calculated the Spearmen rank correlation coefficient to test the strength of association between the two mortality risk rankings. For the Spearman rank correlation coefficient the null hypothesis 0 H is that the observed ranks of mortality risks in 1999 and 2000 are positively correlated against the alternative 1 H that they are independent, hence there has been no significant change in ranks. For Mann-Whitney U test, the null hypothesis 0 H is that there has been no change in mortality risk ranking from 1999 to 2000 against the alternative 1 H that there has been a shift in the distribution of mortality risk rankings. The test statistic to take account of large samples
where s r represent the Spearman rank correlation coefficient. However, the smaller value of 0.6861 for the Spearman rank correlation coefficient for LLE compared with the corresponding values of probability and EYLL indicates that there seems to be some variation in the age composition of death frequencies with probabilities of deaths remaining unchanged. This may be clearer by considering equation [2] . The interpretation is in the number of death frequencies for infants and childhood diseases that affect LLE. The LLE seem to show some variation from year to year. But, this variation does not seem to be carried through to the EYLL. The reason, we think would have to be in the properties of non-parametric statistics. EYLL is found through a non-linear operation ( ( )
whereas ranking is a linear comparison that does not take into account the size of the difference between any two adjacent numbers. Only their relative size is important. Ranking LLE, EYLL and probability does not take into account what these numbers are explaining or are about. The fact that probabilities vary from 0 to 1 (in Table  4 from 0 to 0.16704) and that LLE vary from 0 to 66.77 i.e. the concentration or dispersion of these numbers, has nothing to do with their rank. Consequently, their product could provide a different ranking not necessarily showing any systematic dominance of either probability or LLE. As an example from Table 4 , "Other causes of prenatal morbidity and mortality" probability ranks 6 and LLE ranks 5, but EYLL ranks first. Taking another example at the bottom of the Table  4 , we see that conditions "Anthrax" and "Schis-tosomiasis" rank 140 in probability, but the LLE's are 78 and 71 while the corresponding EYLL have remained unchanged at 140. While for "Erysipelas" that has probability rank of 140 and LLE rank of 140, the corresponding EYLL rank is 144. The EYLL measure of risk averages somewhat non-linearly the information content of LLE and probability of death. The weights that are given to each element in this product are unity, i.e. giving equal weight to each, but distributions are different. j p varies from 0 to 0.16704 (theoretically 0 to 1) and LLE is distributed from 0 to 66.77 (hypothetically up to 100 yr). Thus EYLL is a measure of risk that tells us, in a non-linear way, how much risk there is in every condition in terms of so many probable life years. In order to test for correlation in the ranks of mortality risks we use a large sample approximation (20). Our data includes 151 pairs of observations, thus z scores are calculated which are approximately distributed as standard normal. If both r and s r in Table 5 were to be considered, they show very significant positive correlation between mortality risk ranks. The values are statistically significant at 0.001level. The z scores which are approximately N (0,1), are significant. The probability of a z= 4 is 0.99997 see (21). Thus, we could not reject the null hypothesis of positive correlation between 1999 and 2000 mortality risk rankings and the two sets of risk rankings are highly correlated. With the Mann-Whitney U test in Table 5 we do not reject the null hypothesis and thus conclude that there were no shifts within the distribution of our mortality risk rankings. The results are statistically significant at 0.05 level. The test results in this section indicate that mortality risk measures offered in section 2 are stable across the two. Thus, these risk measures are robust across time and relay risk information consistently.
Conclusion
This study emphasizes the significance of considering measures of mortality risk that take into account life expectancies at different ages as well as discounted and lagged symptom effects. Our results confirm findings in (5, 18) that a major reordering of mortality risk ranks takes place once we allow for the risk weighting measures. The most significant risks facing the population in both studies are heart conditions. Cancer also appears ranking high in (5) as in here. Nevertheless, aggregation and classification of health conditions make comparison difficult between this study and others. The results of nonparametric tests in Section 3, confirms that the risk rankings have remained the same for the two years. However, it has not been possible to see how public regulations could change mortality risk rankings in Iran. It has not been possible to find the corresponding regulations and the relevant data. Such impacts and their research are thought to occupy future research and we hope that this study may provide some encouragement in that respect. 
